Drug intelligence / Profile preview

NCThera

Development stage
Preclinical
Lead developer
Flavocure Biotech
Modality
Nanoparticles → Drug Delivery Systems
01

Overview

NCThera is a proprietary theranostic nanoparticle platform developed by Flavocure in collaboration with Baylor College of Medicine. It is part of the broader NanoCaflanone™ Platform and is specifically engineered to deliver therapeutic payloads across the blood-brain barrier (BBB). The platform is described as configurable, allowing it to engage multiple molecular targets depending on the specific therapeutic application. NCThera is currently in preclinical development for the treatment of central nervous system (CNS) disorders and various oncology indications.

Brand names
NCThera
Other names
NanoCaflanone PlatformNanoCaflanone™ Platform
02

Targets

AURK (Aurora kinase)CK2 (Casein kinase II subunit alpha)CSF1R (Macrophage colony-stimulating factor receptor)FLT3 (Fms related receptor tyrosine kinase 3)PIM2 (Proto-oncogene serine/threonine-protein kinase Pim2)PTPN11 (Tyrosine-protein phosphatase non-receptor type 11)

Beyond the preview

Go deeper on NCThera.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NCThera.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call